Literature DB >> 26189939

Francisella tularensis aortitis.

M Briere1, A Kaladji2, F Douane3, J P Breux4, P Touroult-Jupin5, S Boisset6, S Edouard7, C Biron8, D Boutoille8.   

Abstract

Francisella tularensis, the agent of tularemia, is a Gram-negative coccobacillus primarily pathogen for animals and occasionally for humans. The clinical manifestations of tularemia include pneumonia, ulceroglandular, oropharyngeal, or typhoidal disease. Rare manifestations are also described, but to our knowledge, we describe here the first case of F. tularensis aortitis in a human. Diagnosis was confirmed by the presence of F. tularensis in blood culture, by the presence of F. tularensis DNA in the aortic biopsy and by specific IgG and IgM responses against the bacteria. The outcome was favorable after surgery and specific antimicrobial therapy.

Entities:  

Keywords:  Aortitis; Atherosclerosis; Bacteremia; Infrequent presentation; Tularemia

Mesh:

Substances:

Year:  2015        PMID: 26189939     DOI: 10.1007/s15010-015-0824-4

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  7 in total

1.  Francisella tularensis endocarditis.

Authors:  C A Tancik; J A Dillaha
Journal:  Clin Infect Dis       Date:  2000-02       Impact factor: 9.079

2.  Tularemia endocarditis from domestic pet exposure.

Authors:  Irving E Salit; W Conrad Liles; Christopher Smith
Journal:  Am J Med       Date:  2013-08-01       Impact factor: 4.965

3.  10 years of surveillance of human tularaemia in France.

Authors:  A Mailles; V Vaillant
Journal:  Euro Surveill       Date:  2014-11-13

4.  Clinical recognition and management of tularemia in Missouri: a retrospective records review of 121 cases.

Authors:  Ingrid B Weber; George Turabelidze; Sarah Patrick; Kevin S Griffith; Kiersten J Kugeler; Paul S Mead
Journal:  Clin Infect Dis       Date:  2012-08-21       Impact factor: 9.079

Review 5.  Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations.

Authors:  Anders Sjöstedt
Journal:  Ann N Y Acad Sci       Date:  2007-03-29       Impact factor: 5.691

Review 6.  New approaches to diagnosis and therapy of tularemia.

Authors:  Arne Tärnvik; May C Chu
Journal:  Ann N Y Acad Sci       Date:  2007-04-27       Impact factor: 5.691

7.  Francisella tularensis bacteria associated with feline tularemia in the United States.

Authors:  Marilynn A Larson; Paul D Fey; Steven H Hinrichs; Peter C Iwen
Journal:  Emerg Infect Dis       Date:  2014-12       Impact factor: 6.883

  7 in total
  4 in total

1.  Tularemia: A Case Series of Patients Diagnosed at the National Reference Center for Rickettsioses From 2008 to 2017.

Authors:  Anne Darmon-Curti; François Darmon; Sophie Edouard; Aurélie Hennebique; Thomas Guimard; Guillaume Martin-Blondel; Timothée Klopfenstein; Jean-Philippe Talarmin; Didier Raoult; Max Maurin; Pierre-Edouard Fournier
Journal:  Open Forum Infect Dis       Date:  2020-09-19       Impact factor: 3.835

2.  Isolation of Francisella tularensis and Yersinia pestis from Blood Cultures by Plasma Purification and Immunomagnetic Separation Accelerates Antibiotic Susceptibility Determination.

Authors:  Ronit Aloni-Grinstein; Ofir Schuster; Shmuel Yitzhaki; Moshe Aftalion; Sharon Maoz; Ida Steinberger-Levy; Raphael Ber
Journal:  Front Microbiol       Date:  2017-02-28       Impact factor: 5.640

Review 3.  Spectrum of Large- and Medium-Vessel Vasculitis in Adults: Neoplastic, Infectious, Drug-Induced, Autoinflammatory, and Primary Immunodeficiency Diseases.

Authors:  Fabian Lötscher; Roxana Pop; Pascal Seitz; Mike Recher; Luca Seitz
Journal:  Curr Rheumatol Rep       Date:  2022-08-03       Impact factor: 4.686

Review 4.  Francisella tularensis, Tularemia and Serological Diagnosis.

Authors:  Max Maurin
Journal:  Front Cell Infect Microbiol       Date:  2020-10-26       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.